Allarity Therapeutics, Inc. (NASDAQ: ALLR), a clinical-stage pharmaceutical company focused on personalized cancer treatments, has announced a significant update to its Board of Directors. Jesper Høiland, a seasoned executive with over three decades of experience in the pharmaceutical industry, has been appointed to the board, effective immediately. This move comes as Joseph Vazzano prepares to step down on June 30, 2025, after two years of service.

Mr. Høiland's appointment is seen as a strategic addition to Allarity's leadership, given his extensive background in global pharmaceutical commercialization and executive roles. His tenure as President and EVP of Novo Nordisk's U.S. operations, along with leadership positions at Radius Health and Ascendis Pharma, underscores his capability to steer companies through critical phases of growth and development. Currently, he also holds board positions at SciBase Holding AB, ALK-Abello A/S, and Flen Health SA.

The transition occurs at a pivotal moment for Allarity, as the company advances its Phase 2 clinical trials for stenoparib, a novel dual PARP and WNT pathway inhibitor. Jerry McLaughlin, Chairman of the Board, expressed enthusiasm about Høiland's joining, highlighting the value of his experience during this period of clinical momentum. McLaughlin also extended gratitude to Vazzano for his contributions, particularly in strengthening the company's governance and operational focus.

Thomas Jensen, CEO of Allarity Therapeutics, remarked on the immediate impact Høiland has had since beginning his consultancy role in October 2024. Jensen emphasized Høiland's strategic advice and his deep understanding of the commercialization process for investigational drugs as key assets for Allarity's future. With Høiland's global network and leadership experience, Allarity is poised to navigate the challenges of bringing personalized cancer treatments to market.

Oslo police have issued a stark warning to parents about the dangers of encrypted messaging applications on children's phones, stating there is "no reason" for minors to use such services. During a digital parenting meeting streamed online Sunday afternoon, authorities highlighted how platforms including Telegram, Signal, WhatsApp, and Zangi are being exploited by criminal networks to recruit young people for serious offenses.

Section leader Astri Johanne Holm of Oslo East's local police station emphasized that adults have been "too naive" about children's online activities. "Be interested in what your child is doing on social platforms," Holm advised parents. "There's no reason for a child or youth to walk around with an encrypted app on their phone." The warning comes amid growing concerns about criminal groups targeting vulnerable minors through digital channels.

Recent police operations have resulted in multiple arrests of underage individuals across Norway, with cases linked to criminal networks including Sweden's Foxtrot network. Authorities report that children as young as eleven are being recruited for criminal activities. Holm noted that while many people use encrypted apps legally to protect privacy, criminals exploit these platforms to avoid scrutiny from both police and parents.

The digital parenting event attracted significant public interest, with between 5,000 and 10,000 people following the broadcast across Facebook, YouTube, Instagram, and Discord platforms. During the session, parents submitted over 200 questions about monitoring children's online activity without violating their privacy. Police recommended maintaining open dialogue and curiosity about children's apps and interests as the best prevention strategy, while also implementing broader measures including collaboration with child protection services and schools.